CY1115979T1 - ANTIBODIES AGAINST MYOSTATIN - Google Patents
ANTIBODIES AGAINST MYOSTATINInfo
- Publication number
- CY1115979T1 CY1115979T1 CY20151100122T CY151100122T CY1115979T1 CY 1115979 T1 CY1115979 T1 CY 1115979T1 CY 20151100122 T CY20151100122 T CY 20151100122T CY 151100122 T CY151100122 T CY 151100122T CY 1115979 T1 CY1115979 T1 CY 1115979T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antibodies
- antibodies against
- against myostatin
- myostatin
- increasing
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Αντισώματα κατά της μυοστατίνης ταυτοποιούνται τα οποία χαρακτηρίζονται ως έχοντα υψηλή συγγένεια και μπορεί να είναι χιμαιρικά, ανθρωποποιημένα ή πλήρως ανθρώπινα αντισώματα, ανοσοσυζεύγματα των αντισωμάτων ή αντιγονοδεσμευτικά θραύσματα αυτών. Τα αντισώματα της εφεύρεσης είναι χρήσιμα για αύξηση της μυϊκής μάζας, αύξηση της οστικής πυκνότητας, ή για την αντιμετώπιση διάφορων διαταραχών σε είδη θηλαστικών και πτηνών.Anti-myostatin antibodies are identified which are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, antibody immunoconjugates or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for treating various disorders in mammalian and avian species.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72573805A | 2005-10-12 | 2005-10-12 | |
| EP06816225.4A EP1951755B1 (en) | 2005-10-12 | 2006-10-05 | Anti-myostatin antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115979T1 true CY1115979T1 (en) | 2017-01-25 |
Family
ID=58457073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100122T CY1115979T1 (en) | 2005-10-12 | 2015-02-06 | ANTIBODIES AGAINST MYOSTATIN |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1115979T1 (en) |
-
2015
- 2015-02-06 CY CY20151100122T patent/CY1115979T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA92504C2 (en) | Anti-myostatin monoclonal antibody | |
| NO20064788L (en) | Anti-myostatin-anistoffer | |
| NO20082073L (en) | Anti-myostatin antibodies | |
| CY1120365T1 (en) | ANTIBODIES AGAINST IL-17 | |
| CY1113224T1 (en) | NEW ANTI-PLLGF ANTIBODY | |
| CY1114784T1 (en) | ANTIBODIES AGAINST HARDNESS | |
| MX2024004322A (en) | Antibodies comprising modified heavy constant regions. | |
| ATE545657T1 (en) | TGF-BETA ANTIBODIES | |
| ATE526987T1 (en) | DR5 ANTIBODIES AND THEIR USE | |
| DE602006013029D1 (en) | ANTI-EGFR ANTIBODY | |
| WO2016081746A8 (en) | Antibodies comprising modified heavy constant regions | |
| ATE502052T1 (en) | MONOCLONAL ANTIBODIES TO THE HUMAN ANTI-MÜLLERIAN HORMONE RECEPTOR TYPE II (AMHR-II) | |
| CY1116167T1 (en) | PHARMACEUTICAL COMPOSITIONS GUIDED ON ERB-B1 | |
| ATE530195T1 (en) | BISPECIFIC SINGLE CHAIN FV ANTIBODIES MOLECULES AND METHODS OF APPLICATION THEREOF | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| EA202191769A1 (en) | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | |
| CY1118918T1 (en) | B cell extinction agents, such as ENANTI-CD20 antibodies or their fragments for the treatment of chronic fatigue syndrome | |
| CY1115979T1 (en) | ANTIBODIES AGAINST MYOSTATIN | |
| CY1113928T1 (en) | ANTI-MYOSTATIN ANTIBODIES | |
| EA201992797A1 (en) | ANTIBODIES CONTAINING MODIFIED CONSTANT HEAVY CHAIN AREAS | |
| CY1116949T1 (en) | M-CSF-SPECIAL monoclonal antibody and its uses | |
| CY1110683T1 (en) | ANTI-EGFR ANTIBODIES |
